GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value ($000): $227,217 (100.0% shares, 0.0% debt)

Holdings (33)

CONNECTURE INC 25.1%
Value ($000) $56,956 Shares 5,502,965 Est. Cost $9.01 Unrealized
HYPERION THERAPEUTICS INC 10.1%
Value ($000) $22,950 Shares 500,000 Est. Cost $25.57 Unrealized
VNDA VANDA PHARMACEUTICALS INC 5.7%
Value ($000) $12,914 Shares 1,388,599 Est. Cost $11.30 Unrealized 0.0%
OM2 ORTHOFIX INTL N V 4.7%
Value ($000) $10,767 Shares 300,000 Est. Cost $34.16 Unrealized
ADAMAS PHARMACEUTICALS INC 4.7%
Value ($000) $10,645 Shares 608,650 Est. Cost $17.46 Unrealized
OCERA THERAPEUTICS INC 4.1%
Value ($000) $9,249 Shares 1,963,777 Est. Cost $6.20 Unrealized
ALIMERA SCIENCES INC 3.8%
Value ($000) $8,675 Shares 1,731,550 Est. Cost $6.86 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 3.7%
Value ($000) $8,511 Shares 1,941,144 Est. Cost $3.55 Unrealized +11.7%
DERMA SCIENCES INC 3.6%
Value ($000) $8,283 Shares 977,923 Est. Cost $12.35 Unrealized
VCEL VERICEL CORP 3.4%
Value ($000) $7,718 Shares 2,086,028 Est. Cost $2.85 Unrealized +19.7%
VERSARTIS INC 3.1%
Value ($000) $7,072 Shares 385,000 Est. Cost $18.37 Unrealized
SUCAMPO PHARMACEUTICALS INC 3.1%
Value ($000) $7,002 Shares 450,000 Est. Cost $15.56 Unrealized
STEMLINE THERAPEUTICS INC 3.0%
Value ($000) $6,877 Shares 475,200 Est. Cost $14.47 Unrealized
ARADIGM CORP 2.8%
Value ($000) $6,338 Shares 1,002,962 Est. Cost $8.85 Unrealized
ASND ASCENDIS PHARMA A S 2.6%
Value ($000) $5,896 Shares 339,863 Est. Cost $17.35 Unrealized
ALCOBRA LTD 2.4%
Value ($000) $5,539 Shares 983,786 Est. Cost $5.63 Unrealized
DYAX CORP 1.7%
Value ($000) $3,953 Shares 235,950 Est. Cost $16.75 Unrealized
HRTX HERON THERAPEUTICS INC 1.7%
Value ($000) $3,929 Shares 270,000 Est. Cost $11.27 Unrealized 0.0%
TENAX THERAPEUTICS INC 1.6%
Value ($000) $3,614 Shares 1,108,593 Est. Cost $3.93 Unrealized
AMPIO PHARMACEUTICALS INC 1.4%
Value ($000) $3,174 Shares 421,500 Est. Cost Unrealized
ENTA ENANTA PHARMACEUTICALS INC 1.3%
Value ($000) $3,062 Shares 100,000 Est. Cost $38.91 Unrealized 0.0%
EBS EMERGENT BIOSOLUTIONS INC 1.3%
Value ($000) $2,956 Shares 102,791 Est. Cost $22.90 Unrealized +25.3%
SUNESIS PHARMACEUTICALS INC 1.1%
Value ($000) $2,545 Shares 1,038,652 Est. Cost $2.45 Unrealized
ATHERSYS INC 1.1%
Value ($000) $2,391 Shares 830,200 Est. Cost Unrealized
MELA SCIENCES INC 0.6%
Value ($000) $1,464 Shares 569,591 Est. Cost $2.57 Unrealized
BELLICUM PHARMACEUTICALS INC 0.5%
Value ($000) $1,159 Shares 50,000 Est. Cost $23.04 Unrealized
BOVIE MEDICAL CORP 0.5%
Value ($000) $1,147 Shares 480,000 Est. Cost $2.39 Unrealized
VICAL INC 0.4%
Value ($000) $800 Shares 846,762 Est. Cost $1.19 Unrealized
STREAMLINE HEALTH SOLUTIONS 0.2%
Value ($000) $538 Shares 151,611 Est. Cost $6.45 Unrealized
VCYT VERACYTE INC 0.2%
Value ($000) $497 Shares 68,158 Est. Cost $13.38 Unrealized -38.8%
ATHERSYS INC 0.1%
Value ($000) $288 Shares 100,000 Est. Cost Unrealized
OSIRIS THERAPEUTICS INC NEW 0.1%
Value ($000) $214 Shares 12,165 Est. Cost $17.59 Unrealized
MEI PHARMA INC 0.0%
Value ($000) $94 Shares 52,254 Est. Cost $11.25 Unrealized